4015 Stock Overview
Manufactures and markets pharmaceutical products in the Kingdom of Saudi Arabia and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
No risks detected for 4015 from our risk checks.
My Notes
Capture your thoughts, links and company narrative
Jamjoom Pharmaceuticals Factory Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ر.س158.20 |
| 52 Week High | ر.س202.40 |
| 52 Week Low | ر.س104.60 |
| Beta | 0 |
| 1 Month Change | 8.65% |
| 3 Month Change | -16.74% |
| 1 Year Change | 48.41% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 102.82% |
Recent News & Updates
Shareholder Returns
| 4015 | SA Pharmaceuticals | SA Market | |
|---|---|---|---|
| 7D | 0.5% | -1.4% | 0.4% |
| 1Y | 48.4% | 8.5% | -8.2% |
Return vs Industry: 4015 exceeded the SA Pharmaceuticals industry which returned 8.5% over the past year.
Return vs Market: 4015 exceeded the SA Market which returned -8.2% over the past year.
Price Volatility
| 4015 volatility | |
|---|---|
| 4015 Average Weekly Movement | 5.1% |
| Pharmaceuticals Industry Average Movement | 6.2% |
| Market Average Movement | 4.0% |
| 10% most volatile stocks in SA Market | 7.5% |
| 10% least volatile stocks in SA Market | 2.5% |
Stable Share Price: 4015 has not had significant price volatility in the past 3 months compared to the SA market.
Volatility Over Time: 4015's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | n/a | Tarek Youssef Hosni | www.jamjoompharma.com |
Jamjoom Pharmaceuticals Factory Company manufactures and markets pharmaceutical products in the Kingdom of Saudi Arabia and internationally. The company offers products human medicines, nutraceuticals, antibiotics, general analgesics, medicines for treatment of cough, allergy, asthma, heart diseases, blood pressure, diarrhea, vomiting, ulcer, and acidity, as well as various skin infections, cancer diseases, eye drops and ointments, and cosmeceuticals. Jamjoom Pharmaceuticals Factory Company was founded in 1994 and is based in Jeddah, the Kingdom of Saudi Arabia.
Jamjoom Pharmaceuticals Factory Company Fundamentals Summary
| 4015 fundamental statistics | |
|---|---|
| Market cap | ر.س11.07b |
| Earnings (TTM) | ر.س349.40m |
| Revenue (TTM) | ر.س1.27b |
31.7x
P/E Ratio8.7x
P/S RatioIs 4015 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4015 income statement (TTM) | |
|---|---|
| Revenue | ر.س1.27b |
| Cost of Revenue | ر.س488.93m |
| Gross Profit | ر.س778.81m |
| Other Expenses | ر.س429.41m |
| Earnings | ر.س349.40m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 4.99 |
| Gross Margin | 61.43% |
| Net Profit Margin | 27.56% |
| Debt/Equity Ratio | 0% |
How did 4015 perform over the long term?
See historical performance and comparison